✦ LIBER ✦

Mo1277 Frequency, Risk Factors, and Adverse Sequelae of Bone Loss in Patients With Ostomy for Inflammatory Bowel Diseases

✍ Scribed by Gupta, Supriya; Wu, Xianrui; Moore, Travis; Shen, Bo

Book ID: 122252315
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 189 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)62310-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sa1277 Incidence, Risk Factors and Clini

Sa1277 Incidence, Risk Factors and Clinical Characteristics of Lymphoma in Korean Patients With Inflammatory Bowel Disease

✍ Soo-kyung Park; Byong Duk Ye; Suk-Kyun Yang; Dong-Hoon Yang; Kee Wook Jung; Kyun 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 187 KB

The frequency of low bone mineral densit

The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases

✍ Yasser EZZAT; Khaled HAMDY 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 249 KB

P310 Toxicity of thiopurines in patients

P310 Toxicity of thiopurines in patients with inflammatory bowel disease: Frequency and risk factors

✍ Ben Mustapha, N.; Labidi, A.; Serghini, M.; Fekih, M.; Boubaker, J.; Filali, A. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 47 KB

Mo1198 Risk of Pancreatitis With Tumor N

Mo1198 Risk of Pancreatitis With Tumor Necrosis Factor-Alpha Inhibitors Among Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adverse Event Reporting System

✍ Stobaugh, Derrick J.; Samo, Salih; Deepak, Parakkal; Ehrenpreis, Eli D. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 493 KB

A prospective analysis of the incidence

A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease

✍ Naganuma, Makoto; Kunisaki, Reiko; Yoshimura, Naoki; Takeuchi, Yoshiaki; Watanab 📂 Article 📅 2012 🏛 Springer Japan 🌐 English ⚖ 212 KB

Risk of malignant lymphoma in patients w

Risk of malignant lymphoma in patients with inflammatory bowel diseases: A Dutch nationwide study

✍ A.C.W. Vos; N. Bakkal; R.C. Minnee; M.K. Casparie; D.J. de Jong; G. Dijkstra; P. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 2 views

Background: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents are important for maintaining disease control in most patients with inflammatory bowel diseases (IBDs); however, their use has been associated with the development of malignant lymphoma. The purpose